Showing results (111-120 of 302) with videos related to
Sort By:
Pageof 31
European Journal of Cancer (Oxford, England : 1990)|April 17, 2016
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapyLisa Zimmer, Simone M Goldinger, Lars Hofmann, et al.European Journal of Cancer (Oxford, England : 1990)|April 18, 2016
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapyLars Hofmann, Andrea Forschner, Carmen Loquai, et al.Oncotarget|June 15, 2018
The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physiciansKatharina C Kähler, Christine Blome, Andrea Forschner, et al.Gut|December 17, 2017
Sebaceous tumours: more than skin deepFinja Jockenhöfer, Tobias T Schimming, Jörg Schaller, et al.Journal for Immunotherapy of Cancer|August 6, 2020
Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?Ferdinand Seith, Andrea Forschner, Benjamin Weide, et al.Cancer Medicine|December 22, 2017
Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanomaJessica C Hassel, Kristina Buder-Bakhaya, Carolin Bender, et al.Frontiers in Immunology|May 29, 2024
Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumabOskar Krueger, Robin Eisenburger, Alpaslan Tasdogan, et al.Journal of Cancer Research and Clinical Oncology|February 22, 2022
TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapyJulia Eckardt, Christopher Schroeder, Peter Martus, et al.International Journal of Environmental Research and Public Health|July 27, 2022
eHealth Literacy in German Skin Cancer PatientsHenner Stege, Sara Schneider, Andrea Forschner, et al.Immunotherapy|January 5, 2019
Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasisTeresa Amaral, Ioanna Tampouri, Thomas Eigentler, et al.Pageof 31